For the Inventor, By the Inventor

Enter assignee name

Bergenbio Asa

USPTO Granted Patents = 13

% Expired Patents = 38.5

EPO Patents = 4

Trademarks = 5

Forward Citations = 15

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

David Robert Micklem (8 out of 11 patents)

Linn Nilsson (7 out of 8 patents)

Sergej Kiprijanov (6 out of 14 patents)

4. Lavina Ahmed (6 out of 7 patents)

5. James Bradley Lorens (5 out of 14 patents)

6. Tone Sandal (3 out of 4 patents)

7. Hallvard Haugen (3 out of 3 patents)

8. Stuart Thomas Onions (2 out of 67 patents)

9. John Paul Watts (2 out of 11 patents)

10. Jason John Shiers (2 out of 6 patents)

11. Mohammed Abdul Quddus (2 out of 2 patents)

12. Joseph William Wrigglesworth (2 out of 6 patents)

13. Colin Peter Sambrook-Smith (2 out of 4 patents)

14. Alan Naylor (2 out of 65 patents)

15. Derek John Londesbrough (2 out of 11 patents)

13 patents: Sort by Forward Citations

1. 11732048 - Anti-axl antagonistic antibodies (2023-08-22),

2. 11584796 - Anti-Axl antagonistic antibodies (2023-02-21),

3. 11534440 - Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus (2022-12-27),

4. 11198734 - Anti-Axl antagonistic antibodies (2021-12-14),

5. 11186643 - Anti-Axl antibodies (2021-11-30),

6. 11059893 - Humanized anti-AXL antibodies (2021-07-13),

7. 11035008 - Biomarkers for cancer (2021-06-15),

8. 10766861 - Pharmaceutically active compounds (2020-09-08),

9. 10336702 - Pharmaceutically active compounds (2019-07-02),

10. 10317405 - Methods of detecting Akt3 and administering Ax1 inhibitor (2019-06-11),

11. 9975954 - Anti-Axl antibodies (2018-05-22),

12. 9975953 - Anti-Axl antibodies (2018-05-22),

13. 9783801 - Methods for creating and identifying functional RNA interference elements (2017-10-10),

Bergenbio Asa is a biotechnology company based in Bergen, Norway, specializing in the development of innovative therapies for cancer treatment. The company focuses on advancing its proprietary drug candidates through clinical trials, leveraging its expertise in biopharmaceutical research. Bergenbio is committed to addressing unmet medical needs in oncology by utilizing cutting-edge technology and scientific knowledge to create effective therapeutic solutions. Its research initiatives aim to enhance patient outcomes and contribute to the evolving landscape of cancer care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#3 in Bergen

#127 in Norway

#44,988 in the World

Bergenbio Asa

Forward Citations = 15

21 inventors:

David Robert Micklem (8 out of 11 patents)

Linn Nilsson (7 out of 8 patents)

Sergej Kiprijanov (6 out of 14 patents)

4. Lavina Ahmed (6 out of 7 patents)

5. James Bradley Lorens (5 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…